Level Four Advisory Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-47,032
Closed -$1.01M – 886
2024
Q1
$1.01M Hold
47,032
– – 0.06% 299
2023
Q4
$1.01M Sell
47,032
-1,217
-3% -$22.5K 0.06% 296
2023
Q3
$897K Buy
48,249
+7,092
+17% +$166K 0.06% 301
2023
Q2
$1.04M Buy
41,157
+547
+1% +$13.8K 0.06% 279
2023
Q1
$1.05M Buy
+40,610
New +$1.09M 0.07% 269
2021
Q3
– Sell
-2,747
Closed -$457K – 626
2021
Q2
$457K Sell
2,747
-57
-2% -$9.24K 0.03% 422
2021
Q1
$510K Sell
2,804
-529
-16% -$123K 0.04% 378
2020
Q4
$666K Buy
3,333
+2,154
+183% +$438K 0.05% 312
2020
Q3
$258K Sell
1,179
-266
-18% -$56.3K 0.02% 466
2020
Q2
$275K Buy
+1,445
New +$253K 0.02% 472

Other funds holding TDOC

Level Four Advisory Services's TDOC Position: Q2 2024 in Review

Level Four Advisory Services sold out of Teladoc Health (TDOC) in Q2 2024, closing a stake of 47,032 shares — an estimated $1.01M sold.

Level Four Advisory Services first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $1.05M in Q1 2023. 407 funds tracked by Wall St. Rank hold TDOC as of Q2 2024.

  • Level Four Advisory Services reported no remaining Teladoc Health position as of Q2 2024 after selling out during the quarter.
  • Level Four Advisory Services sold 47,032 Teladoc Health shares in Q2 2024, an estimated $1.01M.
  • Level Four Advisory Services first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Level Four Advisory Services's Teladoc Health position peaked at $1.05M in Q1 2023.
  • 407 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2024.

Based on Level Four Advisory Services's 13F filing for Q2 2024, filed 9 Aug 2024.